※ PTMD 2.0 database Online Browse Options

Browse result for Systemic lupus erythematosus

※ introduction

    Lupus, technically known as systemic lupus erythematosus (SLE), is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. Symptoms vary among people and may be mild to severe. Common symptoms include painful and swollen joints, fever, chest pain, hair loss, mouth ulcers, swollen lymph nodes, feeling tired, and a red rash which is most commonly on the face. Often there are periods of illness, called flares, and periods of remission during which there are few symptoms. The cause of SLE is not clear. It is thought to involve a combination of genetics and environmental factors. Among identical twins, if one is affected there is a 24% chance the other one will also develop the disease. Female sex hormones, sunlight, smoking, vitamin D deficiency, and certain infections are also believed to increase a person's risk. The mechanism involves an immune response by autoantibodies against a person's own tissues. These are most commonly anti-nuclear antibodies and they result in inflammation. Diagnosis can be difficult and is based on a combination of symptoms and laboratory tests. There are a number of other kinds of lupus erythematosus including discoid lupus erythematosus, neonatal lupus, and subacute cutaneous lupus erythematosus. There is no cure for SLE, but there are experimental and symptomatic treatments. Treatments may include NSAIDs, corticosteroids, immunosuppressants, hydroxychloroquine, and methotrexate. Although corticosteroids are rapidly effective, long-term use results in side effects. Alternative medicine has not been shown to affect the disease. Men have higher mortality. SLE significantly increases the risk of cardiovascular disease, with this being the most common cause of death. While women with lupus have higher risk pregnancies, most are successful. Rate of SLE varies between countries from 20 to 70 per 100,000. Women of childbearing age are affected about nine times more often than men. While it most commonly begins between the ages of 15 and 45, a wide range of ages can be affected. Those of African, Caribbean, and Chinese descent are at higher risk than those of European descent. Rates of disease in the developing world are unclear. Lupus is Latin for "wolf": the disease was so-named in the 13th century as the rash was thought to appear like a wolf's bite.

Reference
Wiki: Systemic lupus erythematosus



PTMD IDUniProt AccessionEntrez IDGene NameProtein NameOrganism
PTMD00917Q047595588
PRKCQ
Protein kinase C theta type
Homo sapiens
PTMD00247P16671948
CD36
Platelet glycoprotein 4
Homo sapiens
PTMD00095Q15109177
AGER
Advanced glycosylation end product-specific receptor
Homo sapiens
PTMD00313P080476667
SP1
Transcription factor Sp1
Homo sapiens
PTMD00049P31749207
AKT1
RAC-alpha serine/threonine-protein kinase
Homo sapiens
PTMD00041P498412932
GSK3B
Glycogen synthase kinase-3 beta
Homo sapiens
PTMD00201P627536194
RPS6
Small ribosomal subunit protein eS6
Homo sapiens
PTMD00224P6280512150
H4C1
Histone H4
Homo sapiens
PTMD00225P6843183508
H3C1
Histone H3.1
Homo sapiens
PTMD01086P337783018
H2BC3
Histone H2B type 1-B
Homo sapiens
PTMD01388P027411401
CRP
C-reactive protein [Cleaved into: C-reactive protein]
Homo sapiens
PTMD01414O149744659
PPP1R12A
Protein phosphatase 1 regulatory subunit 12A
Homo sapiens
PTMD01482P067026280
S100A9
Protein S100-A9
Homo sapiens
PTMD01493P086216625
SNRNP70
U1 small nuclear ribonucleoprotein 70 kDa
Homo sapiens
PTMD01579P287992896
GRN
Progranulin [Cleaved into: Paragranulin; Granulin-1 ; Granulin-2 ; Granulin-3 ; Granulin-4 ; Granulin-5 ; Granulin-6 ; Granulin-7 ]
Homo sapiens
PTMD01581P293505777
PTPN6
Tyrosine-protein phosphatase non-receptor type 6
Homo sapiens
PTMD01596P325191997
ELF1
ETS-related transcription factor Elf-1
Homo sapiens
PTMD01719Q025563394
IRF8
Interferon regulatory factor 8
Homo sapiens
PTMD01825Q86WV634006
STING1
Stimulator of interferon genes protein
Homo sapiens
PTMD00572P2935115170
Ptpn6
Tyrosine-protein phosphatase non-receptor type 6
Mus musculus
PTMD00630P6280610004
H4c1
Histone H4
Mus musculus